Metabolic Health
Explore medicines and research compounds linked with appetite, blood sugar, weight and metabolic health. Some are well established, while others are still being tested.
Why people explore metabolic health. Explore medicines and research compounds linked with appetite, blood sugar, weight and metabolic health. Some are well established, while others are still being tested.
Peptides changing the conversation around metabolic health
Appetite, blood sugar, weight and the way the body handles energy are closely connected. Some peptides in this area are already established treatments, while newer ones are being studied to see whether they can offer something different or build on what already works.
Semaglutide
GLP-1 receptor agonist with extensive diabetes and weight-management research.
Tirzepatide
Dual incretin agonist studied across diabetes, obesity and related outcomes.
Retatrutide
Triple-receptor agonist in late-stage metabolic research.
Cagrilintide
Amylin analogue investigated in weight and metabolic programmes.
MOTS-c
Mitochondrial-derived peptide investigated in metabolic and exercise biology.
Tesamorelin
GHRH analogue studied in a defined indication involving visceral adipose tissue.
NAD+
Central cellular coenzyme involved in redox chemistry and energy metabolism.
NMN
NAD+ precursor studied in metabolic health, insulin sensitivity and ageing biology.
NR
Oral NAD+ precursor with substantial human biomarker research.